Skip to main content

Table 1 Patient Baseline Characteristics by Cohort

From: A preoperative nomogram predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: a multicenter retrospective study

 

Training cohort (n = 233)

Validation cohort 1 (n = 16)

Validation cohort 2 (n = 20)

No. of patients

%

No. of patients

%

No. of patients

%

Sex

 Male

208

89.3

15

93.75

17

85.0

 Female

25

10.7

1

6.25

3

15.0

Age, years

 Median

53.0

53.0

53.5

 IQR

48.0–60.0

47.3–61.8

47.8–62.0

LT criteria

 Milan

95

40.8

14

87.5

14

70.0

 Hangzhou

42

18.0

2

12.5

4

20.0

 Over Hangzhou

96

41.2

0

0

2

10.0

Smoke

 Yes

128

54.9

13

81.2

12

60.0

 No

105

45.1

3

18.8

8

40.0

Alcohol

 Yes

77

33.0

10

62.5

8

40.0

 No

156

67.0

6

37.5

12

60.0

BMI

 Median

22.8

23.9

21.5

 IQR

21.1–25.1

21.2–25.6

19–22.9

AFP, ng/mL

 Median

13.9

31.1

174.6

 IQR

3.4–256.8

6.2–426.1

6.9–2915.2

CEA, ng/ml

 Median

2.6

1.3

2.8

 IQR

1.8–4.1

1.0–1.9

1.8–3.8

TB, μmol/mL

 Median

26.0

25.1

26.1

 IQR

15–55.5

10.4–120.8

15.7–76.6

Albumin, g/L

 Median

34.0

37.9

35.8

 IQR

30.4–38.3

34.5–40.7

18.3–44.1

ALT, U/L

 Median

34.0

33.5

35.8

 IQR

20.5–60.5

21.5–62.8

18.3–44.1

AST, U/L

 Median

45.0

32.0

47.6

 IQR

31–80

24.3–110.3

26.2–74.1

Hypertension

 Yes

40

17.2

2

12.5

5

25.0

 No

193

82.8

14

87.5

15

75.0

Diabetes

 Yes

26

11.2

2

12.5

4

20.0

 NO

207

88.8

14

87.5

16

80.0

Ascites

 No

142

60.9

9

56.3

13

65.0

 Mild

70

30.0

6

37.5

1

5.0

 Severe

21

9.1

1

6.3

6

30.0

HBeAg

 Positive

56

24.0

15

93.8

17

85.0

 Negative

177

76.0

1

6.2

3

15.0

Blood type

 Matched

189

81.1

15

93.8

19

95.0

 Unmatched

44

18.9

1

6.2

1

5.0